190 related articles for article (PubMed ID: 11680650)
21. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
[TBL] [Abstract][Full Text] [Related]
22. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
23. Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation.
Kjerrulf M; Grdic D; Kopf M; Lycke N
Scand J Immunol; 1998 May; 47(5):401-7. PubMed ID: 9627122
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine.
Foss DL; Murtaugh MP
Vaccine; 1999 Feb; 17(7-8):788-801. PubMed ID: 10067684
[TBL] [Abstract][Full Text] [Related]
25. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization.
VanCott JL; Kobayashi T; Yamamoto M; Pillai S; McGhee JR; Kiyono H
Vaccine; 1996 Apr; 14(5):392-8. PubMed ID: 8735550
[TBL] [Abstract][Full Text] [Related]
26. Regulation of IgA synthesis at mucosal surfaces.
Fagarasan S; Honjo T
Curr Opin Immunol; 2004 Jun; 16(3):277-83. PubMed ID: 15134775
[TBL] [Abstract][Full Text] [Related]
27. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
Periwal SB; Kourie KR; Ramachandaran N; Blakeney SJ; DeBruin S; Zhu D; Zamb TJ; Smith L; Udem S; Eldridge JH; Shroff KE; Reilly PA
Vaccine; 2003 Jan; 21(5-6):376-85. PubMed ID: 12531635
[TBL] [Abstract][Full Text] [Related]
28. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
Chen KS; Strober W
Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
[TBL] [Abstract][Full Text] [Related]
29. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
Lycke N
Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
[TBL] [Abstract][Full Text] [Related]
30. Orally administered cholera toxin prevents murine intestinal T cells from staphylococcal enterotoxin B-induced anergy.
Iijima H; Takahashi I; Hiroi T; Shimaoka M; Kawano S; Nagano K; Hori M; Kiyono H
Gastroenterology; 1998 Nov; 115(5):1197-204. PubMed ID: 9797375
[TBL] [Abstract][Full Text] [Related]
31. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
32. Roundtrip ticket for secretory IgA: role in mucosal homeostasis?
Corthésy B
J Immunol; 2007 Jan; 178(1):27-32. PubMed ID: 17182536
[TBL] [Abstract][Full Text] [Related]
33. Mucosal addressin cell-adhesion molecule-1 controls plasma-cell migration and function in the small intestine of mice.
Schippers A; Leuker C; Pabst O; Kochut A; Prochnow B; Gruber AD; Leung E; Krissansen GW; Wagner N; Müller W
Gastroenterology; 2009 Sep; 137(3):924-33. PubMed ID: 19450594
[TBL] [Abstract][Full Text] [Related]
34. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
[TBL] [Abstract][Full Text] [Related]
35. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
36. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson CO; Ealding W
J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
[TBL] [Abstract][Full Text] [Related]
38. History of oral tolerance and mucosal immunity.
Brandtzaeg P
Ann N Y Acad Sci; 1996 Feb; 778():1-27. PubMed ID: 8610963
[TBL] [Abstract][Full Text] [Related]
39. Peyer's patch dendritic cells as regulators of mucosal adaptive immunity.
Sato A; Iwasaki A
Cell Mol Life Sci; 2005 Jun; 62(12):1333-8. PubMed ID: 15971108
[TBL] [Abstract][Full Text] [Related]
40. In defense of mucosal surfaces. Regulation and manipulation of the mucosal immune system.
Elson CO
Adv Exp Med Biol; 1997; 412():373-85. PubMed ID: 9192044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
